Portfolio News

Elite Comfort Solutions Appoints Chris Chrisafides As Chief Executive Officer

NEWNAN - Elite Comfort Solutions LLC (ECS) today announced that the board of directors has selected Chris Chrisafides as its Chief Executive Officer.

Chrisafides most recently led Dow Chemical’s North American $1.0+ billion polyurethane division as the Commercial Vice President. Prior to that he served in a variety of senior leadership roles, including General Manager and Global Business Development Director at Rohm & Haas.

“Chris brings a unique background of deep industry knowledge, strong operational leadership and strategic growth experience which will continue to position ECS to be the market leader in the specialty bedding and home furnishings markets. Recognized and respected throughout the industry, Chris has an impeccable track record of building value, and driving innovation in every business he has served. We are delighted to welcome him to the Elite Comfort Solutions team,” said Tim Zappala, Elite Comfort Solutions Chairman and Partner at Arsenal Capital Partners.

Headquartered in Newnan, Georgia, ECS was formed in 2016 by Arsenal Capital Partners. Through the combination of Pacific Urethanes, Elite Foam, and certain assets of Hickory Springs Manufacturing, Arsenal has built ECS into a leading specialty foam business. Elite Comfort Solutions has a national network of 12 production facilities and over 800 employees throughout the U.S. With its broad and deep industry position, ECS is uniquely qualified to provide e-commerce, retail and OEM customers the most advanced technology solutions in the polyurethane foam market today.

Mr. Chrisafides succeeds Dino Rossi who served as interim CEO and will now move into a board advisory role. Mr. Zappala added, “We are very thankful to Dino for his valuable help and guidance as we searched for a permanent CEO for ECS and we look forward to his continued contributions at the Board level.”

About Arsenal Capital Partners

Formed in 2000, Arsenal Capital Partners is a leading New York-based private equity firm that invests in lower middle-market specialty industrial and healthcare companies. Arsenal makes investments in sectors where the firm has significant prior knowledge and experience. The firm targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm’s operational improvement capabilities. Since inception, Arsenal has raised institutional equity investment funds totaling $2.975 billion.